Clinical trial Recruiting at 1 site Interventional Ages 24 Weeks to 34 Weeks

Intervention to support neurodevelopment in preterm infants

Official title: Effects of a Parent-preterm Proximity and Calm Intervention (NeuroN-QI) on the Neurodevelopment of Preterm Infants: A Randomized Pragmatic Clinical Trial

Run by St. Justine's Hospital · NCT06087744 · Data updated 2026-11-12

This study tests a special program for preterm infants that includes skin-to-skin contact with parents and soothing sounds to see if it helps their brain development.

Quick facts

Study typeInterventional
Ages24 Weeks to 34 Weeks
SexAll
Enrollment124 (estimated)
SponsorSt. Justine's Hospital
Academic / other
Locations2 sites (Montreal, Quebec and 1 other locations)
StatusRecruiting
StartedNovember 23, 2023
Main results expectedOctober 2026
Study endsOctober 2027
Registry record updatedApril 19, 2024
Trial IDNCT06087744 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include preterm infants born between 24 and 33 weeks of gestational age who are ready for skin-to-skin contact.

Probably not a fit

Patients with congenital anomalies, genetic disorders, or those requiring mechanical ventilation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

NeuroN-QI evaluates the effects of an intervention designed for preterm infants that includes skin-to-skin contact with parents and auditory stimulation through the parents' voice. The intervention also incorporates calm periods with olfactory stimulation using breast milk, all while maintaining appropriate light and noise levels. This approach aims to enhance neurodevelopmental outcomes in preterm infants by providing positive sensory experiences during their critical early weeks. The study will involve both parents and infants, particularly focusing on those born between 24 and 33 weeks of gestational age.

Why it matters

Potential benefit: If successful, this intervention could significantly improve neurodevelopmental outcomes for preterm infants.

How similar studies have gone: Other studies have shown promising results with similar interventions focusing on sensory stimulation for preterm infants.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for preterm infants:

* born between 24 and 33 6/7 weeks GA;
* ready for SSC

Inclusion criteria for mothers and fathers:

* agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant;
* mothers express breast milk for their preterm infants

For twin births (twin pregnancies), fathers will also be invited to participate in the study, so that both infants can participate in the study.

Exclusion criteria for preterm infants:

* congenital anomalies or genetic disorders
* intraventricular hemorrhage \> grade II
* are small for GA defined as birth weight \<10th percentile
* on postnatal day 19 (maximum days targeted for study start)
* are still receiving analgesics, sedatives, paralyzing agents
* are under mechanical ventilation

Exclusion criteria mothers and fathers:

* are aged \<18 years;
* have a physical condition that does not allow the SSC
* abuse illicit substances or alcohol that could influence stress, anxiety and parent- child interactions
* feed their preterm infant exclusively with commercial infant formula
* mothers had a breast surgery that could influence their breast milk production
* do not speak, read or write in French or in English

Where it's running

  • CHU Sainte-Justine
    Montreal, Quebec, Canada
    Recruiting
  • Cusm
    Montreal, Quebec, Canada
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.